Suvoda
Suvoda is a technology company that provides cloud-based clinical trial software focused on interactive response technology (IRT), electronic clinical outcome assessments (eCOA), and electronic patient-reported outcomes (ePRO) for global biopharmaceutical sponsors and CROs. Its platform is used to manage patient randomization, trial supply, and patient data collection in complex, often oncology and CNS, clinical studies. Suvoda generates revenue through subscription and service fees for its software and implementation, integration, and support services.
- IT Consulting & Implementation
- Clinical Trial & Research Software
- Revenue
- $90.0M
- Employees
- 450
- Founded
- 2012
- Headquarters
- Conshohocken, United States of America
What 41 Arbolus experts think of Suvoda
NPS ratings for Suvoda are notably high, with at least 70% of expert respondents scoring it 8 or above, and a contingent of 9s and 10s. Renewal intent is positive among high spenders and long-term users, while early-stage or low spend users express some uncertainty. The majority of experts highlight platform flexibility, proactive customer support, reliability with protocol amendments, and quality of integration as consistent themes. Relative weaknesses in EDC integration and advanced analytics appear as occasional concerns, but overall sentiment is unambiguously positive.Overall Customer Sentiment: Positive
Who reviewed Suvoda
- C-Suite 44% (18)
- Director 41% (17)
- Manager 15% (6)
Employer names and spend open in the full report, along with the other 38 customers.
Everything 41 customers told us about Suvoda.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
41 Net Promoter Score, from 41 scored reviews- Promoters 22
- Passives 14
- Detractors 5
Cumulative NPS by month
+0 over 6 months- Apr 8
- May 8
- Jun 8
- Jul 8
- Aug 8
- Sep 8
Net Promoter Score across 5 reviews, accumulated up to each month. Category median 27 across 5 companies.
Praised
- AI Feature Expansion
- Unified Technology Stack
- Greater Customization for Multinational Trials
- Flexibility and Fast Protocol Amendments
Criticised
- Competitive Pressure from AI-Enhanced Platforms
- Price Escalation Leads to Switching Risk
- Failure in Service Quality or Integration
- Lagging in Real-Time Analytics
What customers say
Renewal intent
Plan to renew 67%Plan to renew, by seniority
- 82% 11 answers
- 58% 12 answers
- 50% 4 answers
- 8.6/10 Average score from customers who will renew
- 6.7/10 Average score from undecided customers
Top alternatives
Most weighed by Suvoda customersReport
For people who use Suvoda
Do you use Suvoda at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 41 customers of Suvoda have already contributed
Takes a few minutes. Your identity stays anonymous.